Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 431

Results For "Health"

5430 News Found

Israeli researchers warn about the return of Delta variant
News | May 05, 2022

Israeli researchers warn about the return of Delta variant

The research was supported by the BGU Coronavirus Challenge and the Israeli Ministry of Health.


Sawai Man Singh Medical College (SMS), Jaipur collaborates with Intuitive India
Healthcare | May 05, 2022

Sawai Man Singh Medical College (SMS), Jaipur collaborates with Intuitive India

The workshop was organized by the Department of Urology as a first step to enabling government medical colleges in Rajasthan to offer the latest surgical technology


JBCPL emerges as the fastest growing pharma company: Report
News | May 05, 2022

JBCPL emerges as the fastest growing pharma company: Report

Ranked 25th with an impressive growth rate of 29% among Indian pharma companies in FY 2021-22


Mediso acquires nuclear medicine supplier Bartec Technologies
Biotech | May 05, 2022

Mediso acquires nuclear medicine supplier Bartec Technologies

In the UK, Bartec has been synonymous with Mediso products for 18 years, proof of a successful partnership


Evonik opens its first Zero Liquid Discharge plant in India
Sustainability | May 05, 2022

Evonik opens its first Zero Liquid Discharge plant in India

Evonik in association with Remondis has opened its first plant in India to ensure Zero Liquid Discharge. It is located at Dombivli in Western Maharashtra


Merck invests $110 million to expand production site in China
News | May 05, 2022

Merck invests $110 million to expand production site in China

Company will expand the existing production site in Wuxi to significantly increase biopharma single-use assemblies and custom design capabilities


14.9 million excess deaths associated with the Covid-19 pandemic in 2020 and 2021
News | May 05, 2022

14.9 million excess deaths associated with the Covid-19 pandemic in 2020 and 2021

The report has estimated 4.74 million deaths for India in 2020 and 2021,


Juniper Biologics signs exclusive license agreement with Helsinn for infigratinib (INN) for the emerging markets including India
Biotech | May 04, 2022

Juniper Biologics signs exclusive license agreement with Helsinn for infigratinib (INN) for the emerging markets including India

Infigratinib is not FDA-, Health Canada- or Therapeutics Goods Association-approved for any other indication


HPRA completes audit of Biocon Biologics New mAbs drug substance facility
Biotech | May 04, 2022

HPRA completes audit of Biocon Biologics New mAbs drug substance facility

The inspection report contains no 'critical' observations and only one of the deficiencies is categorized as 'major' which is being addressed expeditiously in consultation with the regulatory agency


New study links gut microbiota strains with more severe strokes and poorer post-stroke recovery
Healthcare | May 04, 2022

New study links gut microbiota strains with more severe strokes and poorer post-stroke recovery

The study, presented at the European Stroke Organisation Conference (ESOC 2022) pinpointed specific groups of bacteria associated with poorer neurological recovery from ischaemic stroke both in the acute phase (24 hours) and after three months